368
Views
160
CrossRef citations to date
0
Altmetric
Research Article

Vesicular aceclofenac systems: A comparative study between liposomes and niosomes

, MSc, , &
Pages 499-512 | Received 15 Jul 2007, Accepted 13 Mar 2008, Published online: 07 May 2008

References

  • Agarwal R, Katare OP, Vyas SP. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antipsoriatic drug dithranol. Int J Pharm 2001; 228: 43–52
  • Aggarwal D, Kaur IP. Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharm 2005; 290: 155–159
  • Ahn BN, Kim SK, Shim CK. Preparation and evaluation of proliposomes containing propranolol hydrochloride. J Microencapsulation 1995; 12: 363–375
  • Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur J Pharm Biopharm 2005; 59: 485–490
  • Alvarez-Larena A, Piniella JF, Carrasco E, Ginebreda A, Julia S, Germain G. Crystal structure and spectroscopic study of 2-[(2,6-dichlorophenyl) amino] phenylacetoxyacetic acid (Aceclofenac). J Crystallographic Spectroscopic Res 1992; 22: 323–328
  • Arica B, Ozer AY, Ercan MT, Hincal AA. Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes. J Microencapsulation 1995; 12: 469–485
  • Baillie AJ, Florence AT, Hume LR, Muirhead GT, Rogerson A. The preparation and properties of niosomes- non-ionic surfactant vesicles. J Pharm Pharmacol 1985; 37: 863–868
  • Betageri GV. Liposomal encapsulation and stability of dideoxyinosine triphosphate. Drug Dev Ind Pharm 1993; 19: 531–539
  • Betz G, Aeppli A, Menshutina N, Leuenberger H. In vivo comparison of various liposome formulations for cosmetic application. Int J Pharm 2005; 296: 44–54
  • Bhatia A, Kumar R, Katare OP. Tamoxifen in topical liposomes: Development, characterization and in-vitro evaluation. J Pharm Pharm Sci 2004; 7: 252–259
  • Blume A, Janesan M, Ghyczy M, Gareiss J. Interaction of phospholipid liposomes with lipid model mixtures for stratum corneum lipids. Int J Pharm 1993; 99: 219–228
  • British Pharmacopoeia. Her Majesty's Stationary Office, London 1998; I: 33
  • Budavari S, O’Neil MJ, Smith A, Heckelman PE, Kinneary JF. The Merck Index, an encyclopedia of chemicals, drugs and biological, 12th ed. Merck and Co.Inc., Whitehouse station, NJ 1996; 5
  • Crommelin DJA, Grit M, Talsama H, Zuidam NJ. Liposomes as carriers for drugs and antigens: Approaches to preserve their long term stability. Drug Dev Ind Pharm 1994; 20: 547–556
  • Devaraj GN, Parakh SR, Devraj R, Apte SS, Rao BR, Rambhau D. Release studies on niosomes containing fatty alcohols as bilayer stabilizers instead of cholesterol. J Coll Interf Sci 2002; 251: 360–365
  • Du Plessis J, Ramachandran C, Weiner N, Muller DG. The influence of lipid composition and lamellarity of liposomes on the physical stability of liposomes upon storage. Int J Pharm 1996; 127: 273–278
  • Egbaria K, Weiner N. Topical application of liposomal preparations. Cosmetics Toiletries 1991; 106: 79–93
  • El Gazayerly ON, Hikal AH. Preparation and evaluation of acetazolamide liposomes as an ocular delivery system. Int J Pharm 1997; 158: 121–127
  • El Ridy MS, Khalil RM. Free versus liposome encapsulated lignocaine hydrochloride topical applications. Pharmazie 1999; 54: 682–684
  • Fang J, Hong C, Chiu W, Wang Y. Effect of liposomes and niosomes on skin permeation of enoxacin. Int J Pharm 2001a; 219: 61–72
  • Fang J, Yu S, Wu P, Hwang Y, Tsai Y. In vitro skin permeation of estradiol from various proniosome formulations. Int J Pharm 2001b; 215: 91–99
  • Fatouros DG, Hatzidimitriou K, Antimisiaris SG. Liposomes encapsulating prednisolone and prednisolone-cyclodextrin complexes: Comparison of membrane integrity and drug release. Eur J Pharm Sci 2001; 13: 287–296
  • Fresta M, Puglisi G. Corticosteroid dermal delivery with skin-lipid liposomes. J Contr Rel 1997; 44: 141–151
  • Fresta M, Ventura CA, Mezzasalma E, Puglisi G. A calorimetric study on the idebenone-phospholipid membrane interaction. Int J Pharm 1998; 163: 133–143
  • Friedman DI, Schwarz JS, Weisspapir M. Submicron emulsion vehicle for enhanced transdermal delivery of steroidal and nonsteroidal anti-inflammatory drugs. J Pharm Sci 1995; 84: 324–329
  • Gabriels M, Plaizier-Vercammen J. Physical and chemical evaluation of liposomes containing artesunate. J Pharm Biomed Anal 2003; 31: 655–667
  • Ganesan MG, Weiner ND, Flynn GL, Ho NFH. Influence of liposomal drug entrapment on percutaneous absorption. Int J Pharm 1984; 20: 139–154
  • Gianasi E, Cociancich F, Uchegbu IF, Florence AT, Duncan R. Pharmaceutical and biological characterization of a doxorubicin-polymer conjugate (PK1) entrapped in sorbitan monstearate Span 60 niosomes. Int J Pharm 1997; 148: 139–148
  • Glavas-Dodov M, Goracinova K, Mladenovska K, Fredro-Kumbaradzi E. Release profile of lidocaine HCl from topical liposomal gel formulation. Int J Pharm 2002; 242: 381–384
  • Guinedi AS, Mortada ND, Mansour S, Hathout RM. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm 2005; 306: 71–82
  • Hao Y, Zhao F, Li N, Yang Y, Li K. Studies on a high encapsulation of colchicine by a niosome system. Int J Pharm 2002; 244: 73–80
  • Hathout R, Mansour S, Mortada ND, Guinedi AS. Liposomes as ocular delivery system for acetzolamide: In vitro and in vivo studies. AAPS Pharm Sci Tech 2007; 8, article E1–E2
  • Insel PA. Analgesic-antipyretics and anti-inflammatory agents: Drugs employed in the treatment of rheumatoid arthritis and gout. The pharmacological basis of therapeutics, LS Goodman, A Gilman, TW Rall, AS Nies, P Taylor. McGraw-Hill International editions, New York 1992; 638–681
  • Joshi MR, Misra A. Liposomal budesonide for dry powder inhaler: preparation and stabilization. AAPS Pharm Sci Tech 2001; 2, article 25 44–53
  • Junginger HE, Hofland HEJ, Bouwstra JA. Liposomes and niosomes interactions with human skin. Cosmetics Toiletries 1991; 106: 45–50
  • Kulkarni SB, Betageri GV, Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsulation 1995; 12: 229–246
  • Law SL, Lo WY, Lin M. Increase of liposome stability by incorporation of bovine serum albumin. Drug Dev Ind Pharm 1994; 20: 1411–1423
  • Maestrelli F, Gonzalez-Rodrjguez ML, Rabasco AM, Mura P. Preparation and characterization of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int J Pharm 2005; 298: 55–67
  • Maghraby GMME, Campbell M, Finnin BC. Mechansims of action of novel skin lipid liposomes. Int J Pharm 2005; 305: 90–104
  • Manconi M, Sinico C, Valenti D, Loy G, Fadda AM. Niosomes as carriers for tretinoin I. Preapartion and properties. Int J Pharm 2002; 234: 237–248
  • Manconi M, Valenti D, Sinico C, Lai F, Loy G, Fadda AM. Niosomes as carriers for tretinoin II. Influence of vesicular incorporation on tretinoin photostability. Int J Pharm 2003; 260: 261–272
  • Manosroi A, Kongkaneramit L, Manosroi J. Stability and transdermal absorption of topical Amphotericin B liposome formulations. Int J Pharm 2004; 270: 279–286
  • Manosroi A, Podjanasoonthon K, Manosroi J. Development of novel topical tranexamic acid liposome formulations. Int J Pharm 2002; 235: 61–70
  • Manosroi A, Wongtrakul P, Manosroi J, Sakai H, Sugawara F, Yuasa M, Abe M. Characterization of vesicles prepared with various non ionic surfactants mixed with cholesterol. Coll Surf B Biointerfaces 2003; 30: 129–138
  • Martel-Pelletier J, Cloutier JM, Pelletier JP. Effects of aceclofenac and diclofenac on synovial inflammatory factors in human osteoarthritis. Clin Drug Invest 1997; 14: 226–232
  • Mei Z, Chen H, Weng T, Yang Y, Yang X. Solid lipid nanoparticles and microemulsion for topical delivery of triptolide. Eur J Pharm Biopharm 2003; 56: 189–196
  • Mei Z, Li X, Wu Q, Hu S, Yang X. The research on the anti-inflammatory activity and hepatotoxicity of triptolide- loaded solid lipid nanoparticles. Pharmacol Res 2005; 51: 345–351
  • Moribe K, Maruyama K, Iwatsuru M. Molecular localization and state of Amphotericin B in PEG liposomes. Int J Pharm 1999; 193: 97–106
  • Morilla MJ, Benavidez P, Lopez MO, Bakas L, Romero EL. Development and in vitro characterization of a benznidazole liposomal formulation. Int J Pharm 2002; 249: 89–99
  • Nagarsenker MS, Joshi AA. Preparation, characterization and evaluation of liposomal dispersions of lidocaine. Drug Dev Ind Pharm 1997; 23: 1159–1165
  • Nagarsenker MS, Londhe VY. Preparation and evaluation of a liposomal formulation of sodium cromoglicate. Int J Pharm 2003; 251: 49–56
  • Nagarsenker MS, Londhe VY, Nadkarni GD. Preparation and evaluation of liposomal formulations of tropicamide for ocular delivery. Int J Pharm 1999; 190: 63–71
  • Namdeo A, Jain NK. Niosomal delivery of 5-fluorouracil. J Microencapsulation 1999; 16: 731–740
  • Naresh RAR, Pillai GK, Udupa N, Chandrashekar G. Anti-inflammatory activity of niosome encapsulated diclofenac sodium in arthritic rats. Indian J Pharmacol 1994; 26: 46–48
  • Nasseri B. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. Int J Pharm 2005; 300: 95–101
  • Ozer AY, Talsama H. Preparation and stability of liposomes containing 5-fluorouracil. Int J Pharm 1989; 55: 185–191
  • Padamwar MN, Pokharkar VB. Development of vitamin loaded topical liposomal formulation using factorial design approach: Drug deposition and stability. Int J Pharm 2006; 320: 37–44
  • Pasero G, Marcolongo R, Serni U, Parnham MJ, Ferrer F. Multi-center, double blind comparative study of the efficacy and safety of aceclofenac and diclofenac in the treatment of rheumatoid arthritis. Curr Med Res Opin 1995; 13: 305–315
  • Patel VB, Misra AN. Encapsulation and stability of clofazimine liposomes. J Microencapsulation 1999; 16: 357–367
  • Pavelic Z, Skalko-Basnet N, Schubert R. Liposomal gels for vaginal drug delivery. Int J Pharm 2001; 219: 139–149
  • Penzes T, Blazso G, Aigner Z, Falkay G, Eros I. Topical absorption of piroxicam from organogels—in vitro and in vivo correlations. Int J Pharm 2005; 298: 47–54
  • Pereira-Lachataignerais J, Pons R, Panizza P, Courbin L, Rouch J, Lopez O. Study and formation of vesicle systems with low polydispersity index by ultrasound method. Chem Phys Lipids 2006; 140: 88–97
  • Rogerson A, Cummings J, Florence AT. Adriamycin-loaded niosomes-drug entrapment, stability and release. J Microencapsulation 1987; 4: 321–328
  • Rolland A. Particulate carriers in dermal and transdermal drug delivery: Myth or reality?. Pharmaceutical particulate carriers: Therapeutic applications, A Rolland. Marcel Dekker, New York 1993; 367–421
  • Ruckmani K, Jayakar B, Ghosal SK. Nonionic surfactant vesicles (Niosomes) of cytarabine hydrochloride for effective treatment of leukemias: Encapsulation, storage and in vitro release. Drug Dev Ind Pharm 2000; 26: 217–222
  • Shahiwala A, Misra A. Studies in topical application of niosomally entrapped nimesulide. J Pharm Pharm Sci 2002; 5: 220–225
  • Sharma BB, Jain SK, Vyas SP. Topical liposome system bearing local anaesthetic lignocaine: Preparation and evaluation. J Microencapsulation 1994; 11: 279–286
  • Sihorkar V, Vyas SP. Polysaccharide coated niosomes for oral drug delivery formulation and in vitro stability studies. Pharmazie 2000; 55: 107–113
  • Sinico C, De Logu A, Lai F, Valenti D, Manconi M, Loy G, Bonsignore L, Fadda AM. Liposomal incorporation of Artemisia arboscens L. essential oil and in vitro antiviral activity. Eur J Pharm Biopharm 2005; 59: 161–168
  • Skalko-Basnet N, Pavelic Z, Becirevic-Lacan M. Liposomes containing drug and cyclodextrin prepared by the one-step spray-drying method. Drug Dev Ind Pharm 2000; 26: 1279–1284
  • Tabbakhian M, Tavakoli N, Jaafari MR, Daneshamouz S. Enhancement of follicular delivery of finasteride by liposomes and niosomes 1. In vitro permeation and in vivo deposition studies using hamster flank and ear models. Int J Pharm 2006; 323: 1–10
  • Taylor KMG, Taylor G, Kellaway IW, Stevens J. Drug entrapment and release from multilamellar and reverse-phase evaporation liposomes. Int J Pharm 1990; 58: 49–55
  • Uchegbu IF, Duncan R. Niosomes containing N-(2-hydroxypropyl) methacrylamide copolymer- doxorubicin (PK1): Effect of method of preparation and choice of surfactant on niosome characteristics and a preliminary study of body distribution. Int J Pharm 1997; 155: 7–17
  • Uchegbu IF, Florence AT. Non-ionic surfactant vesicles (niosomes): Physical and pharmaceutical chemistry. Adv Coll Interf Sci 1995; 58: 1–55
  • Uchegbu IF, Vyas SP. Non Ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm 1998; 172: 33–70
  • Vora B, Khopade AJ, Jain NK. Proniosome based transdermal delivery of levonorgesterol for effective contraception. J Contr Rel 1998; 54: 149–165
  • Vyas SP, Kannan ME, Jain S, Mishra V, Singh P. Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 2004; 269: 37–49
  • Vyas SP, Singh R, Asati RK. Liposomally encapsulated diclofenac for sonophoresis induced systemic delivery. J Microencapsulation 1995; 12: 149–154
  • Vyas SP, Venkatesan N. Poly (pthaloyl-L-lysine)-coated multilamellar vesicles for controlled drug delivery: In vitro and in vivo performance evaluation. Pharm Acta Helv 1999; 74: 51–58
  • Yan-yu X, Yun-mei S, Zhi-peng C, Qi-neng P. Prepartion of silymarin proliposome: A new way to increase oral bioavailability of silymarin in beagle dogs. Int J Pharm 2006; 319: 162–168
  • Yoshioka T, Sternberg B, Florence AT. Preparation and properties of vesicles (niosomes) of sorbitan monoesters (Span 20, 40, 60 and 80) and sorbitan triester (Span 85). Int J Pharm 1994; 105: 1–6
  • Zeisig R, Shimada K, Hirota S, Arndt D. Effect of sterical stabilization on macrophage uptake in vitro and on thickness of the fixed aqueous layer of liposomes made from alkylphosphocholines. Biochim Biophys Acta Biomembranes 1996; 1285: 237–245
  • Zhang JH, Zhu JB. A novel method to prepare liposomes containing amikacin. J Microencapsulation 1999; 16: 511–516

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.